当前位置:首页 - 行情中心 - 方盛制药(603998) - 财务分析

方盛制药

(603998)

  

流通市值:38.86亿  总市值:38.86亿
流通股本:4.39亿   总股本:4.39亿

方盛制药(603998)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润0.88亿元,每股收益0.20元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益183541.50万元,未分配利润94518.67万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产305552.17万元,负债122010.67万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入462,773,883.821,746,442,351.51,253,315,302.11834,248,975.63
营业总成本362,507,389.841,446,723,025.151,022,150,726.68683,068,914.91
其他经营收益
营业利润103,710,627.45358,197,148.18299,828,760.83187,112,626.84
利润总额103,637,395.83353,240,974.73299,162,496.92186,493,310.71
净利润87,860,749.44302,635,591.07265,351,950.55166,494,080.22
每股收益
其他综合收益-323,131.29-197,943.06-65,219.22-
综合收益总额87,537,618.15302,437,648.01265,286,731.33166,494,080.22
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计1,013,259,837.071,013,841,193.65987,649,695.53940,136,070.64
非流动资产:
非流动资产合计2,042,261,870.532,041,931,796.252,043,853,141.372,116,407,088.06
资产总计3,055,521,707.63,055,772,989.93,031,502,836.93,056,543,158.7
流动负债:
流动负债合计1,120,232,885.41,150,446,404.111,149,548,620.361,167,605,565.8
非流动负债:
非流动负债合计99,873,787.04102,502,339.78129,766,967.57174,190,717.88
负债合计1,220,106,672.441,252,948,743.891,279,315,587.931,341,796,283.68
所有者权益(或股东权益):
归属于母公司股东权益合计1,734,022,158.661,711,676,859.571,672,016,819.11,638,839,547.98
股东权益合计1,835,415,035.161,802,824,246.011,752,187,248.971,714,746,875.02
负债和股东权益合计3,055,521,707.63,055,772,989.93,031,502,836.93,056,543,158.7
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计485,096,127.741,848,435,273.211,302,807,585.71837,217,170.97
经营活动现金流出小计404,910,074.751,463,803,377.751,077,931,339.97707,728,803.3
经营活动产生的现金流量净额80,186,052.99384,631,895.46224,876,245.74129,488,367.67
投资活动产生的现金流量:
投资活动现金流入小计132,821,586.45899,234,528.07640,139,688.45320,696,460.33
投资活动现金流出小计186,221,722.18817,516,244.11588,509,679.01307,298,903.28
投资活动产生的现金流量净额-53,400,135.7381,718,283.9651,630,009.4413,397,557.05
筹资活动产生的现金流量:
筹资活动现金流入小计181,065,375386,020,336342,480,000334,025,000
筹资活动现金流出小计264,966,630.18880,131,386.57745,608,590.67658,260,770.36
筹资活动产生的现金流量净额-83,901,255.18-494,111,050.57-403,128,590.67-324,235,770.36
汇率变动对现金及现金等价物的影响-23,830.36-90,882.9-16,775.9-0.19
现金及现金等价物净增加额-57,139,168.28-27,851,754.05-126,639,111.39-181,349,845.83
期末现金及现金等价物余额214,220,151.24268,170,278.7169,389,737.12114,672,186.92
补充资料:
现金及现金等价物的净增加额--27,851,754.05--181,349,845.83
最新报告期:2026-04-29
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
信达证券唐爱金,章钟涛0.841.001.192026-04-29
开源证券余汝意,巢舒然0.841.011.212026-04-29
东吴证券向潇,朱国广0.841.021.252026-04-27
华泰证券代雯,唐庆雷,张云逸0.830.991.172026-04-27
中邮证券盛丽华,龙永茂0.831.00--2026-04-17
TOP↑